7:30 a.m.

Registration and Breakfast / Exhibit Hall

7:50

Welcome and Introductions

8:00

Management of high-risk breast patients and role of hormone therapy/OCPs
Sabrina Sahini, MD (MCR)

8:30

Circulating Tumor DNA in Breast Cancer Management: Hope or Hype?
Nathaniel Wiest, MD (MCR)

9:00

Management of the axilla and 2026: What´s still necessary?
James Jakub, MD (MCA)

9:30

Future of standardized risk assessment and AI based risk score

Bhavika Patel, MD (MCR)

10:00

Approach to Evaluation and Management of Breast Pain
Sandhya Pruthi, MD (MCR)

10:30

Break / Exhibit Hall

10:45

Breast Skin Lesions/Disorders
Sindhuja Sominidi Damodaran, MD (MCR)

11:15

Beyond Chemotherapy: The Emerging Role of Antibody-Drug Conjugates in Early Breast Cancer
Brenda Ernst, MD (MCA)

11:45

Diagnostic Workup of a Palpable Mass
Bhavika Patel, MD (MCA)

12:15 p.m.

Lunch / Exhibit Hall

Optional Lunch with the Experts for 30 minutes: 12:30pm – 1:00pm (All Welcome)

1:15

Breast cancer risk assessment calculators, IBIS, Gail Model, Can Risk and others- pros and cons
Sabrina Sahini, MD (MCF)

1:45

Risk reducing medications and risks and benefits
Christine Klassen, MD (MCR)

2:15

High-Risk Breast Lesions – When to Operate
Mary Mrdutt, MD (MCA)

2:45

Break / Exhibit Hall

3:00

PANEL DISCUSSION
Sandhya Pruthi MD, Mary Mrdutt MD,

Jen Caramutti P.A.-C., Shana Salik APRN

4:00 p.m.

Adjourn

7:00 a.m.

Breakfast / Exhibit Hall

7:30

Primary Tumor: Less Surgery, Better Outcomes
Barbabra Pockaj, MD (MCA)

8:00

FES-PET Imaging in ER-Positive Breast Cancer: Ready for Prime Time?
Pooja Advani, MBBS, MD (MCF)

8:30

Management of Moderate Hereditary Genetic Mutations- CHEK 2, ATM, PALB 2 and RAD 51 D/C, others
Sarah Mantia, MD (MCF)

9:00

Break / Exhibit Hall

9:15

New BI-RADS version 2025 Reporting- What’s New and Impact on Patient Care/Communication
Katie Hunt, MD (MCR)

9:45

Management strategies of benign lesions- FEA, PASH, papilloma, apocrine metaplasia, radial scar, sclerosing adenosis
Jessie Fraker, MD (MCA)

10:15

Management of the pregnant patient and breast abnormality
Christine Klassen, MD (MCR)

10:45

Contralateral Prophylactic Mastectomy in the Average Risk Patient
Shon Black, MD (MCR)

11:15

Break / Exhibit Hall

11:30

Breast Cancer in the Older Patient: Tailoring Treatment Without Compromise
Brenda Ernst, MD (MCA)

12:00 p.m.

Evaluation of the high-risk patient
Kaitlin Moran, MD (MCF)

12:30

Complications in Breast Surgery, Prevention and Management
Barbara Pockaj, M.D. (MCA)

1:00

Lunch / Exhibit Hall

2:00

PANEL DISCUSSION

Patricia Cronin MD,

and others

3:00 p.m.

Adjourn General Session

4:00 – 6:00 p.m.

Evening with the Faculty Social Hour

7:00 a.m.

Breakfast / Exhibit Hall

7:30

Strategies to manage hair loss in the setting of anti-estrogen therapy and systemic chemotherapy
Sindhuja Sominidi Damodaran, MD (MCR)

8:00

Finding It Earlier, Finding It Better: What's New in Early Detection of Breast Cancer
Pooja Advani, MBBS, MD (MCF)

8:30

Omission of Sentinel Lymph Node Biopsy – Sound Trial
Patricia Cronin, MD (MCA)

9.00

Deescalation of Radiation in Axilla
Kim Corbin – RadOnc (MCR)

9:30

Break / Exhibit Hall

9:45

The Unspoken Side Effect: Recognizing and Managing Sexual Dysfunction After Breast Cancer Treatment
Taryn Smith, MD (MCF)

10:15

Breast Reconstruction – Options patient should know?

Olivia Ho, MD (MCF)

10:45

Management of Common Side Effects from ADCS and Targeted Therapy
Nathaniel Wiest, MD (MCR)

11:15

PANEL DISCUSSION

Oligometastatic Breast Cancer: Is Cure on the Horizon? A Multidisciplinary Perspective
Pooja Advani, MBBS, MD, and Patricia Cronin, MD

12:00 p.m.

Adjourn